Predicting Response to Risperidone Treatment Through Identification of Early-Onset of Antipsychotic Drug Action in Schizophrenia.
Latest Information Update: 03 Oct 2021
At a glance
- Drugs Olanzapine (Primary) ; Risperidone
- Indications Psychotic disorders; Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- Sponsors Eli Lilly and Company
- 01 Jan 2010 Results reported in Neuropsychopharmacology.
- 01 Jan 2010 Secondary endpoint 'Montgomery Asberg Depression Rating Scale' has been met.
- 01 Jan 2010 Primary endpoint 'Positive and Negative Syndrome Scale' has been met.